Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
Date:2/14/2008

ins were 25.4% for the first six months of 2008 compared to 28% for the first six months of 2007. Net income was $3.2 million for the six months ended December 31, 2007, an increase of 65% from the same period in 2006.

Balance Sheet and Cash Flow

The Company had a current ratio of 2.6 to 1 and $4.6 million in cash and accounts receivable on December 31, 2007. The Company reported $1.3 million in short-term notes and no long-term debt. For the first six months of 2008, the Company provided $1.75 million in cash for operations, the main driver for cash flow was net income of $3.2 million and a significant increase in revenues. On January 28, 2008, subsequent to the end of their second quarter, Tianyin announced a private placement of $15.2 million.

"I would like to thank all of the investors who participated in our recent private placement. This capital will be used to significantly expand our production capacity during the coming six to twelve months to meet demand supported by the continued growth in expenditures per capita on Traditional Chinese Medicines (TCMs) and government support for additional cost reimbursement of our products," stated Jiang. "TCM's have been deeply ingrained in Chinese culture for thousands of years and long been perceived by many Chinese to be both safe and efficacious. Strong government support to include more TCM's to the list of medicines subject to reimbursement in the National Medicine Catalog, along with the Chinese SFDA's plan to release more product approvals will be advantageous for the future growth prospects for our large pipeline of new products."

Conference Call

The Company will host a conference call to discuss the 2008 second quarter financial results on Thursday, February 14, 2008 at 4:15 p.m. EST. Interested participants should call 800-762-8908 within the United States, or US +1-480- 629-1990 if calling internationally. It is advisable to dial in approximately 5-10 minutes prior to the 4
'/>"/>

SOURCE Tianyin Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2
... 1 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ), a b...,compounds for the treatment of cardiovascular dis...A,s senior vice president of research and,developm...nces Drug,Discovery & Development of Innovative Th...in Boston, MA., The presentation details are as ...
...Due to its remarkable electronic properties, few l...new material for use in post-silicon devices that ... nanoscale. Now, physicists at the University of ...ch FLG can be etched along flawless, crystallograp...s, a technique that results in atomically precise,...
...ows 15 Percent Quarter-over-Quarter -, PALO ALTO,...VTX ) today reported financial results for the sec... ended June 30, 2008, the Company reported a net l...ares to a net loss of $31.9,million, or $0.53 per ...and,$57.6 million, or $0.97 per share, for the sam...
Other Biology Technology:VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress 2Penn scientists carve functional nanoribbons using super-heated, nano-sized particles of iron 2CV Therapeutics Reports 2008 Second Quarter Financial Results 2CV Therapeutics Reports 2008 Second Quarter Financial Results 3CV Therapeutics Reports 2008 Second Quarter Financial Results 4CV Therapeutics Reports 2008 Second Quarter Financial Results 5CV Therapeutics Reports 2008 Second Quarter Financial Results 6CV Therapeutics Reports 2008 Second Quarter Financial Results 7
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient,s future risk of death, according to published studies. Now, results of a ne
(Date:12/2/2009)PHILADELPHIA Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researc
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Wound Management to Participate at Save A Leg Save a Life Foundation National Conference 5252 1Wound Management to Participate at Save A Leg Save a Life Foundation National Conference 5252 2Wound Management to Participate at Save A Leg Save a Life Foundation National Conference 5252 3Sigma Aldrich 28R 29 Partners With Flow Chemistry Leader ThalesNano to Provide CatCart 28R 29 Catalyst Products for Rapidly Growing Market 5250 1Sigma Aldrich 28R 29 Partners With Flow Chemistry Leader ThalesNano to Provide CatCart 28R 29 Catalyst Products for Rapidly Growing Market 5250 2Sigma Aldrich 28R 29 Partners With Flow Chemistry Leader ThalesNano to Provide CatCart 28R 29 Catalyst Products for Rapidly Growing Market 5250 3New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry 5248 1New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry 5248 2
...ring atomic blast shook the Pacific atoll of Bikin...ecies, however, appear to be locally extinct. , T...n by an international team of scientists from Aust...ands. The expedition examined the diversity and a...the most interesting aspects is that the team dive...
...ts Medical School professor of molecular medicine ...s (mRNAs)opened a dramatic new world of investigat...008 Gairdner International Award, considered one o...es the award with collaborator Gary Ruvkun, PhD, p...th whom he discovered micro miRNAs. Ambros will be...
... Applications, Live Face Detection and Incorpora... Biometric Identification, VILNIU...Neurotechnologija), a provider of high-precision b...ced the availability of two new biometric,software...int recognition,and VeriLook 3.2 SDK for facial re...
Other Biology News:Bikini corals recover from atomic blast 2Bikini corals recover from atomic blast 3UMass Medical School researcher Victor Ambros receives Gairdner Award, Franklin Medal 2UMass Medical School researcher Victor Ambros receives Gairdner Award, Franklin Medal 3VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 2VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 3
...te enterprise microarray informatics platform for ...nalysis. Buy Acuity once and use it forever withou...r Quality Acuity has all the analysis tools you n...ontrol statistics and normalization, all the way t...
...ndustry standard microarray image analysis softwar... analysis tools, visualizations, automation capabi...s included with every GenePix scanner, and it also... all types of arrays. A wide range of spot finding...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, Floppy Disk from PerkinElmer
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
Biology Products: